Literature DB >> 11739311

Activation of lectin-like oxidized low-density lipoprotein receptor-1 induces apoptosis in cultured neonatal rat cardiac myocytes.

E Iwai-Kanai1, K Hasegawa, T Sawamura, M Fujita, T Yanazume, S Toyokuni, S Adachi, Y Kihara, S Sasayama.   

Abstract

BACKGROUND: Lectin-like oxidized LDL receptor-1 (LOX-1) was originally identified as a receptor expressed predominantly in endothelial cells. LOX-1 can also be expressed in other cell types, and the activation of the LOX-1 pathway has been implicated in apoptosis. There have been no reports, however, about LOX-1 expression in cardiac myocytes or regulation of myocardial cell apoptosis by LOX-1. METHODS AND
RESULTS: In primary cardiac myocytes from neonatal rats, immunohistochemical analyses using a specific monoclonal antibody against LOX-1 demonstrated that LOX-1 expression was markedly induced by stimulation with norepinephrine and endothelin-1. LOX-1 expression was upregulated in cardiac myocytes as well as in vessel walls of failing rat hearts in vivo. In the presence of a low concentration of oxidized LDL that did not induce apoptosis by itself, artificial overexpression of LOX-1 in cardiac myocytes in culture resulted in apoptosis. LOX-1 overexpression induced activation of p38 mitogen-activated protein kinase (MAPK) and oxidative stress in cardiac myocytes, as demonstrated by an increase in positive immunostaining for 8-hydroxy-2'-deoxyguanosine. Inhibition of p38 MAPK by cotransfection of a dominant-negative form of MKK6 as well as by administration of a specific inhibitor, SB203580 or FR167653, almost completely blocked the induction of apoptosis by LOX-1 activation. Antioxidant catalase also blocked LOX-1-induced apoptosis as well as activation of p38 MAPK.
CONCLUSIONS: These findings demonstrate that LOX-1 expression in cardiac myocytes is induced by neurohormonal factors activated in heart failure and that LOX-1-dependent apoptosis in these cells requires p38 MAPK, a component of oxidant stress-sensitive signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739311     DOI: 10.1161/hc4901.100381

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

1.  LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse.

Authors:  J Lu; X Wang; W Wang; H Muniyappa; C Hu; S Mitra; B Long; K Das; J L Mehta
Journal:  Gene Ther       Date:  2011-09-22       Impact factor: 5.250

2.  Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis.

Authors:  Tanu Goyal; Sona Mitra; Magomed Khaidakov; Xianwei Wang; Sandeep Singla; Zufeng Ding; Shijie Liu; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2012-01-29       Impact factor: 5.113

3.  Induction of smooth muscle cell-like phenotype in marrow-derived cells among regenerating urinary bladder smooth muscle cells.

Authors:  Akihiro Kanematsu; Shingo Yamamoto; Eri Iwai-Kanai; Isao Kanatani; Masaaki Imamura; Rosalyn M Adam; Yasuhiko Tabata; Osamu Ogawa
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

Review 4.  LOX-1, a new marker of risk and prognosis in coronary artery disease?

Authors:  Valter Lubrano; Silvana Balzan
Journal:  Mol Cell Biochem       Date:  2013-08-11       Impact factor: 3.396

5.  Role of the NF-kappaB signaling cascade and NF-kappaB-targeted genes in failing human hearts.

Authors:  Sudhiranjan Gupta; Subha Sen
Journal:  J Mol Med (Berl)       Date:  2005-08-17       Impact factor: 4.599

6.  Blockade of LOX-1 prevents endotoxin-induced acute lung inflammation and injury in mice.

Authors:  Ping Zhang; Ming-Cheh Liu; Lili Cheng; Mei Liang; Hong-long Ji; Jian Fu
Journal:  J Innate Immun       Date:  2008-10-01       Impact factor: 7.349

7.  LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma.

Authors:  David F Schaeffer; Maziar Riazy; Kuljit S Parhar; Johnny H Chen; Vincent Duronio; Tatsuya Sawamura; Urs P Steinbrecher
Journal:  J Lipid Res       Date:  2009-04-09       Impact factor: 5.922

8.  A method to measure cardiac autophagic flux in vivo.

Authors:  Eri Iwai-Kanai; Hua Yuan; Chengqun Huang; M Richard Sayen; Cynthia N Perry-Garza; Lucy Kim; Roberta A Gottlieb
Journal:  Autophagy       Date:  2008-01-18       Impact factor: 16.016

Review 9.  LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.

Authors:  Suowen Xu; Sayoko Ogura; Jiawei Chen; Peter J Little; Joel Moss; Peiqing Liu
Journal:  Cell Mol Life Sci       Date:  2012-11-03       Impact factor: 9.261

Review 10.  Role of oxidative stress-related biomarkers in heart failure: galectin 3, α1-antitrypsin and LOX-1: new therapeutic perspective?

Authors:  Valter Lubrano; Silvana Balzan
Journal:  Mol Cell Biochem       Date:  2019-11-29       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.